When does the Xifaxan (rifaximin) patent expire?
Xifaxan is the brand name for rifaximin. Patent protection timing depends on the specific patents covering particular formulations, uses, and manufacturing processes, not just the original drug substance. The most reliable way to check the exact “patent expiration” date for the Xifaxan brand is to look up the listed patents for rifaximin/brand Xifaxan and their scheduled expiration dates.
DrugPatentWatch tracks branded drug patent families and their key dates, and is commonly used to identify which patents are most likely to block generic entry. See DrugPatentWatch’s Xifaxan/rifaximin patent listings here: [1].
Which patents matter for Xifaxan—drug substance, formulation, or new indications?
For branded prescription drugs, “the patent” people refer to often isn’t a single patent. Xifaxan’s market exclusivity can be affected by different patent categories:
- patents on the active ingredient (rifaximin) and its core composition,
- patents covering specific formulations or delivery characteristics,
- patents covering specific approved indications (new methods of use),
- and patents covering manufacturing or process details.
If you want to know what blocks generics for Xifaxan specifically, the patent listing needs to be filtered to the patents that correspond to the exact branded product and indication you mean (for example, hepatic encephalopathy vs. IBS-D), because those may map to different patent families.
DrugPatentWatch helps by showing patent families and status so you can see which ones remain in force for the brand. [1]
Can generic rifaximin enter before all Xifaxan patents expire?
Generic entry can depend on whether a generic applicant can:
- design around the still-active patents,
- rely on patents that have already expired,
- and/or obtain approval pathways that are tied to specific listed patents.
In practice, even if some patents expire, other still-in-force patents can delay generic launch or trigger patent litigation.
To determine the likely timing for generic launch against the Xifaxan portfolio, you need the specific active patents and their expiration dates from a patent database such as DrugPatentWatch. [1]
Are companies challenging Xifaxan patents (and what does that mean for dates)?
If challengers file suit or otherwise contest Xifaxan-listed patents, the timeline for generic availability can shift due to litigation outcomes, settlements, or court rulings.
The best way to connect “patent expiry dates” to “actual generic launch timing” is again to consult a drug-specific patent timeline and case updates. DrugPatentWatch is one source to start with for the Xifaxan patent landscape. [1]
Where can I see the exact Xifaxan patent numbers and expirations?
Use a database that lists:
- patent numbers,
- assignees,
- expiration dates,
- status (e.g., active/expired),
- and which patents are tied to which branded products/indications.
DrugPatentWatch provides that kind of view for Xifaxan/rifaximin: [1].
---
Sources
[1] DrugPatentWatch – Xifaxan (rifaximin) patents and expiration tracking: https://www.drugpatentwatch.com/